小方制药(603207.SH)：上半年净利润1.21亿元，同比增长1.69% 拟10派7元

Core Insights - The company reported a revenue of 270 million yuan for the first half of 2025, representing a year-on-year growth of 3.06% [1] - The net profit attributable to shareholders reached 121 million yuan, with a year-on-year increase of 1.69% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was also 121 million yuan, showing a growth of 2.04% year-on-year [1] - Basic earnings per share were reported at 0.75 yuan [1] - The company plans to distribute a cash dividend of 7.00 yuan (including tax) for every 10 shares to all shareholders [1]